Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
108. Pelegri Y, Cerrato G, Martinuzzo LO, et al. Link between anti-CD36 antibodies and thrombosis in the antiphosphilipid syndrome. Clin Exp Rheumatol 2003; 21: 221—224.
109. Daviet L, McGregor JL. Vascular biology of CD36: roles of this new adhesion molecule fanily in different disease states. Thromb Haemost 1997; 78: 65—69.
110. Stone S, Khamashta MA, Poston L. Pla-centation, antiphospholipid syndrome and pregnancy outcome. Lupus 2001; 10: 67—74.
111. Sthoeger ZM, Mozes E, Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA 1993; 90: 6464—6467.
112. Rand JH, Wu X-X, Andree HAM, et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. New Engl J Med 1997; 337:154—160.
113. McCrae KR, DeMichele AM, Pandhi P, et al. Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss. Blood 1993; 82: 2730—2741.
SHS-OOO4.qxd 21.11.2006 16:56 Page 106 •
Насонов Е.Л. Антифосфолипидный синдром.
114. Peacemn AM, Rehnberg KA. The effect of immunoglobulin G fraction from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1995; 199: 1403—1406.
115. Donohoe S, Kingdom JCP, Mackie IJ: Affinity purified human antiphospholipid antibodies bind normal term placenta. Lupus 1999; 8: 525—531.
116. Rote NS, Vogt E, DeVere G, et al. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol 1998, 39: 125—136.
117. Chamley LW, Duncalf AM, Mitchell MD, et al. Action of anticardiolipin and antibodies to beta 2 glycoprotein I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352: 1037—1038.
118. Di Simone N, Meroni PL, Del Papa N, et al. Antiphospholipid antibodies affect trophoblast gonadotrophin secretion and invasiveness by binding directly and through adhered beta 2 gly-coprotein I. Arthritis Rheum 2000; 43: 140—153.
119. Shurtz SR, et al. In vitro effects of anticar-diolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. Am J Reptoduct Immunol 1993; 29: 206—210.
120. Salmon JE, Girardi G, Holers VM. Complement activation as a mediator of antiphos-pholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis 2002; 61: (Suppl II): ii46—ii50.
121. Atkinson JP. Complement system on the attack in autoimmunity. J Clin Invest 2003; 112: 1639—1641.
122. Girardi G, Berman J, Redecha P, et al. Complement C5a receptors and neutrophil mediated fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112: 1644—1654.
123. Berman J, Girardi G, Salmon JE, et al. Tumor necrosis factor-a is an important effector in antiphospholipid-induced pregnancy loss in mice. ACR/ARHP Annual Acientific Meeting, October, 2003, 24—28; 1115 (abst).
124. Sun KH, Liu WT, Tsai CY, Liao TS, Lin WM, Yu CL. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis 1992; 51: 707—12.
125. Khalili A, Cooper RC. A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1991; 85: 365—72.
126. Liou HH, Wang CR, Chou HC et al. Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor—mediated chloride current in snail neurons. Life Sci 1994; 54: 1119—25.
127. Kent M, Alvarez F, Vogt E, Fyffe R, Ng AK, Rote N. Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol 1997; 24: 1725—33.
128. Kent MN, Alvarez FJ, Ng AK, Rote NS. Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain. Exp Neurol 2000; 163: 173—9.
129. DCruz D, Hughes G. Antiendothelial cell antibodies, antiphospholipid antibodies and vascular disease. Vasculitis Science and practice. B Ansell, P Bacon, J Lie, H Yazici (eds). Chapmam & Hall Medical 1996; 65—82.
130. Насонов ЕЛ, Баранов АА, Шилкина НП. Васкулиты и васкулопатии. Ярославль: Издательство "Верхняя Волга", 1999; 613 с.
131. Praprotnic S, Blank M, Meroni PL, et al. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells. Arthritis Rheum 2001; 44: 1483—1494.
132. DCruz D, Houssiau FA., Ramirez G, et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991; 85: 254—261.
133. Navarro M, Cervera R, Font J, et al. Anti-endothelial antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 1997; 6: 521—526.
134. Nylander-Lundqvist E, Back O, Nillsson TK, Rantapaa-Dahlqvist S. Prevalence of anti-endothelial antibodies in patients with autoimmune disease. Clin Rheumatol 1992; 11: 248—263.
135. Van der Zee JM, Siegert CE, de Vreede TA, et al. Characterisation of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol 1991; 84:238—244.
